Adcock Ingram Holdings Limited reported revenue results for the first quarter ended December 31, 2013. For the quarter, the company reported group revenue was 4% ahead of the previous corresponding period, including the Cosme and Datlabs businesses which were not in the comparative period. Revenue in the Southern African business is 4% behind the corresponding period, including a sharp slow-down in the OTC and Prescription Generics portfolios.

The company provided earnings guidance for the six months ending March 31,2014, for the period, the company expects basic earnings per share from continuing operations are to be lower than the previous corresponding period`s figure of 188.0 cents. Headline earnings per share for the period from continuing operations are expected to be lower than the previous corresponding period`s figure of 188.1 cents.